Baxter International lung therapy devices recall classified most serious by USFDA
The FDA said the adaptor may prevent patients from getting enough oxygen from their ventilators, and possibly lead to death if caregivers are not trained properly.
New Delhi: The U.S. Food and Drug Administration (USFDA) on Thursday classified the recall of some Baxter International Inc's lung therapy devices as the most serious type after reports of two deaths.
Medical device maker Baxter in late April recalled about 268 devices distributed between May 28, 2020 and April 19, 2022.
Read also: Pfizer sued for patent infringement over COVID-19 drug Paxlovid
The device, Volara, is used to deliver therapies for several conditions such as for lung complications. Its ventilator adaptor component allows the device to be used with ventilators in home-care settings.
The FDA said the adaptor may prevent patients from getting enough oxygen from their ventilators, and possibly lead to death if caregivers are not trained properly.
Read also: USFDA investigates death of another infant given Abbott formula: Bloomberg
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.